The PE Ratio as of December 2025 (TTM) for Zelira Therapeutics Limited (ZLDAF) is -0.95

According to Zelira Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.95. This represents a change of 70.59% compared to the average of -0.56 of the last 4 quarters.

Zelira Therapeutics Limited (ZLDAF) Historical PE Ratio (quarterly & annually)

How has ZLDAF PE Ratio performed in the past?

The mean historical PE Ratio of Zelira Therapeutics Limited over the last ten years is -7.27. The current -0.95 PE Ratio has changed 1.21% with respect to the historical average. Over the past ten years (40 quarters), ZLDAF's PE Ratio was at its highest in in the December 2010 quarter at 313.88. The PE Ratio was at its lowest in in the December 2017 quarter at -34.82.

Zelira Therapeutics Limited (ZLDAF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Zelira Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zelira Therapeutics Limited (ZLDAF) Average PE Ratio

How has ZLDAF PE Ratio performed in the past?

The current PE Ratio of Zelira Therapeutics Limited (ZLDAF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zelira Therapeutics Limited (ZLDAF) PE Ratio vs. Peers

How is ZLDAF’s PE Ratio compared to its peers?

Zelira Therapeutics Limited’s PE Ratio is greater than ProtoKinetix, Incorporated (-6.69), greater than Acrux Limited (-1.08), greater than AXIM Biotechnologies, Inc. (-2.12), less than HAVN Life Sciences Inc. (-0.01), greater than Algernon Pharmaceuticals Inc. (-1.32), greater than Sigyn Therapeutics, Inc. (-1.00), less than ReNeuron Group plc (-0.01), less than RepliCel Life Sciences Inc. (6.01), greater than Appili Therapeutics Inc. (-1.32), less than Radient Technologies Inc. (0),

Build a custom stock screener for Zelira Therapeutics Limited (ZLDAF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zelira Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zelira Therapeutics Limited (ZLDAF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zelira Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.